Curtin University Homepage
  • Library
  • Help
    • Admin

    espace - Curtin’s institutional repository

    JavaScript is disabled for your browser. Some features of this site may not work without it.
    View Item 
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item

    Development of Kupffer cell targeting type-I interferon for the treatment of hepatitis via inducing anti-inflammatory and immunomodulatory actions

    Access Status
    Fulltext not available
    Authors
    Minayoshi, Y.
    Maeda, H.
    Yanagisawa, H.
    Hamasaki, K.
    Mizuta, Y.
    Nishida, K.
    Kinoshita, R.
    Enoki, Y.
    Imafuku, T.
    Chuang, Victor
    Koga, T.
    Fujiwara, Y.
    Takeya, M.
    Sonoda, K.
    Wakayama, T.
    Taguchi, K.
    Ishima, Y.
    Ishida, T.
    Iwakiri, Y.
    Tanaka, M.
    Sasaki, Y.
    Watanabe, H.
    Otagiri, M.
    Maruyama, T.
    Date
    2018
    Type
    Journal Article
    
    Metadata
    Show full item record
    Citation
    Minayoshi, Y. and Maeda, H. and Yanagisawa, H. and Hamasaki, K. and Mizuta, Y. and Nishida, K. and Kinoshita, R. et al. 2018. Development of Kupffer cell targeting type-I interferon for the treatment of hepatitis via inducing anti-inflammatory and immunomodulatory actions. Drug Delivery. 25 (1): pp. 1067-1077.
    Source Title
    Drug Delivery
    DOI
    10.1080/10717544.2018.1464083
    ISSN
    1521-0464
    School
    School of Pharmacy and Biomedical Sciences
    URI
    http://hdl.handle.net/20.500.11937/71480
    Collection
    • Curtin Research Publications
    Abstract

    Because of its multifaceted anti-inflammatory and immunomodulatory effects, delivering type-I interferon to Kupffer cells has the potential to function as a novel type of therapy for the treatment of various types of hepatitis. We report herein on the preparation of a Kupffer cell targeting type-I interferon, an albumin-IFNa2b fusion protein that contains highly mannosylated N-linked oligosaccharide chains, Man-HSA(D494N)-IFNa2b, attached by combining albumin fusion technology and site-directed mutagenesis. The presence of this unique oligosaccharide permits the protein to be efficiently, rapidly and preferentially distributed to Kupffer cells. Likewise IFNa2b, Man-HSA(D494N)-IFNa2b caused a significant induction in the mRNA levels of IL-10, IL-1Ra, PD-L1 in RAW264.7 cells and mouse isolated Kupffer cells, and these inductions were largely inhibited by blocking the interferon receptor. These data indicate that Man-HSA(D494N)-IFNa2b retained the biological activities of type-I interferon. Man-HSA(D494N)-IFNa2b significantly inhibited liver injury in Concanavalin A (Con-A)-induced hepatitis model mice, and consequently improved their survival rate. Moreover, the post-administration of Man-HSA(D494N)-IFNa2b at 2?h after the Con-A challenge also exerted hepato-protective effects. In conclusion, this proof-of-concept study demonstrates the therapeutic effectiveness and utility of Kupffer cell targeting type-I interferon against hepatitis via its anti-inflammatory and immunomodulatory actions.

    Related items

    Showing items related by title, author, creator and subject.

    • Decreased IP-10 and elevated TGFß1 levels are associated with viral clearance following therapy in patients with hepatitis C virus
      Lee, S.; Varano, J.; Flexman, J.; Cheng, W.; Watson, M.; Rossi, E.; Adams, L.; Bulsara, M.; Price, Patricia (2010)
      The role of pro-fibrogenic cytokines in the outcome of infections with hepatitis C virus (HCV) and the response to treatment with pegylated interferon-alpha (pegIFNa) and ribavirin remains unclear. To address this issue, ...
    • Immunopathogenesis of hepatic flare in HIV/hepatitis b virus (Hbv)-coinfected individuals after the initiation of Hbv-active antiretroviral therapy
      Crane, M.; Oliver, B.; Matthews, G.; Avihingsanon, A.; Ubolyam, S.; Markovska, V.; Chang, J.; Dore, G.; Price, Patricia; Visvanathan, K.; French, M.; Ruxrungtham, K.; Lewin, S. (2009)
      Background. The pathogenesis of and risk factors for hepatic flare (HF) after the initiation of hepatitis B virus (HBV)-active antiretroviral therapy (ART) in HIV/HBV-coinfected individuals is not well understood. Methods. ...
    • Decreased IFNI? production correlates with diminished production of cytokines by dendritic cells in patients infected with hepatitis C virus and receiving therapy
      Hammond, T.; Lee, S.; Watson, M.; Flexman, J.; Cheng, W.; Price, Patricia (2011)
      Toll-like receptor (TLR) expression and the signalling pathways that lead to the production of accessory cytokines by antigen-presenting cells (APCs) both have potential to limit T-cell responses to viral antigens. Here, ...
    Advanced search

    Browse

    Communities & CollectionsIssue DateAuthorTitleSubjectDocument TypeThis CollectionIssue DateAuthorTitleSubjectDocument Type

    My Account

    Admin

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Follow Curtin

    • 
    • 
    • 
    • 
    • 

    CRICOS Provider Code: 00301JABN: 99 143 842 569TEQSA: PRV12158

    Copyright | Disclaimer | Privacy statement | Accessibility

    Curtin would like to pay respect to the Aboriginal and Torres Strait Islander members of our community by acknowledging the traditional owners of the land on which the Perth campus is located, the Whadjuk people of the Nyungar Nation; and on our Kalgoorlie campus, the Wongutha people of the North-Eastern Goldfields.